BioNTech SE (BNTX)
NASDAQ: BNTX · Real-Time Price · USD
109.00
+2.93 (2.76%)
At close: Jan 16, 2026, 4:00 PM EST
108.77
-0.23 (-0.21%)
After-hours: Jan 16, 2026, 7:55 PM EST
BioNTech SE Market Cap
BioNTech SE has a market cap or net worth of $27.35 billion as of January 16, 2026. Its market cap has increased by 0.12% in one year.
Market Cap
27.35B
Enterprise Value
10.59B
1-Year Change
0.12%
Ranking
Category
Stock Price
$109.00
Market Cap Chart
Since October 10, 2019, BioNTech SE's market cap has increased from $2.99B to $27.35B, an increase of 813.24%. That is a compound annual growth rate of 42.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 27.35B | 19.48% |
| Dec 31, 2025 | 22.89B | -16.21% |
| Dec 31, 2024 | 27.32B | 8.89% |
| Dec 29, 2023 | 25.09B | -31.28% |
| Dec 30, 2022 | 36.51B | -41.37% |
| Dec 31, 2021 | 62.26B | 217.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 924.90B |
| Johnson & Johnson | 529.01B |
| AbbVie | 383.08B |
| UnitedHealth Group | 307.04B |
| AstraZeneca | 291.28B |
| Merck & Co. | 275.43B |
| Novartis AG | 273.64B |
| Novo Nordisk | 252.12B |